Soleno Therapeutics (SLNO): SEC Form 3 filed by new insider Huang Michael F.
Stocks in this Quantisnow insightHealth Care
Keep researching SLNO
- SLNO insider tradesEvery buy and sale reported by Soleno Therapeutics Inc. officers, directors and large holders.
- What is Form 3?The initial SEC statement of beneficial ownership filed by a company's officers, directors and 10% holders when they first become insiders.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
SLNO
Soleno Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2014
Get push alerts for SLNO
Full SLNO profile on Quantisnow Follow SLNO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time